KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Asset Utilization Ratio (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Asset Utilization Ratio data on record, last reported at 0.53 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 8.64% year-over-year to 0.53; the TTM value through Dec 2025 reached 0.53, down 8.64%, while the annual FY2025 figure was 0.55, 15.55% down from the prior year.
  • Asset Utilization Ratio reached 0.53 in Q4 2025 per EBS's latest filing, down from 0.55 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.62 in Q4 2021 and bottomed at 0.32 in Q1 2023.
  • Average Asset Utilization Ratio over 5 years is 0.53, with a median of 0.57 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: rose 25.08% in 2021, then plummeted 46.75% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.62 in 2021, then tumbled by 40.13% to 0.37 in 2022, then increased by 13.42% to 0.42 in 2023, then surged by 39.92% to 0.59 in 2024, then fell by 8.64% to 0.53 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.53 in Q4 2025, 0.55 in Q3 2025, and 0.59 in Q4 2024.